comparemela.com

Jiya Acquisition Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

eFFECTOR Therapeutics Reports Third Quarter 2022 Financial

eFFECTOR Therapeutics Appoints Mayank Gandhi, M D , as Chief Business Officer

eFFECTOR Therapeutics Appoints Mayank Gandhi, M D , as Chief Business Officer

26.09.2022 - SAN DIEGO and REDWOOD CITY, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) - eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (“STRIs”) for the treatment of cancer, today announced it . Seite 1

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.